GLYCINE N METHYL TRANSFERASE, A REGULATOR OF CYP1A1
甘氨酸 N 甲基转移酶,CYP1A1 的调节剂
基本信息
- 批准号:2733366
- 负责人:
- 金额:$ 25.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-07 至 1998-12-31
- 项目状态:已结题
- 来源:
- 关键词:CHO cells adenosine triphosphate benzopyrenes binding proteins cytochrome P450 drug metabolism enzyme activity enzyme induction /repression gene deletion mutation genetically modified animals hydroxymethyltransferases laboratory mouse laboratory rat liver cells liver metabolism phosphoproteins site directed mutagenesis
项目摘要
The overall goal of this laboratory is to understand the regulation of
polycyclic hydrocarbon (PAH)- inducible expression of the
cytochrome P4501A1 gene (CYP1A1). This regulation appears to be
mediated by cis elements associated with the gene and trans-acting
proteins. PAHs such as benzo(a)pyrene (B[a]P) can interact with
high affinity and in saturable manner with a rat liver cytosolic 4S
protein that has previously been shown to be identifical with glycine
N-methy1transferase (GNMT). Our preliminary results indicated that
B[a]P can induce the expression of CYP1A1 in the Ah receptor
(AhR)-null mouse and that this PAH (as well as several others)
induce CYP1A1 in CHO cells that have been stably transfected with
the GNMT gene (TCDD) is ineffective in this system). The parent
CHO cells have no GNMT, AhR, or Arnt expression while the
transfectants elaborate only GNMT. Building on these observations,
the specific aims of the current grant are to determine: a) the effects
of B[a]P and 3-methylcholanathrene upon expression of CYP1A1 and
upon the rate of its transcription in the livers of the Ah receptor-
minus knockout mouse and the level of liver GNMT, b) the effects
of introducing the GNMT coding sequence into B[a]P-nonresponsive
CHO cells by measuring the steady-state CYP1A1 mRNA level and
its rate of transcription before and agter B[a]P treatment and by
measuring the stability of the GNMT and its mRNA, c) the site of
phosphorylation of GNMT, the distribution of unphosphorylated and
phosphorylated forms in cytosol and nucleus before/afterB[a]P, the
effects of phosphorylation upon function of GNMT and the nature of
its oligomeric form, d) the dimer-tetramer transition of GNMT by
sedimentation analysis and by chemical crosslinking, and e) nature of
the interaction of phosphorylated (and unphosphorylated) 4S GNMT
with cis elements of CYP1A1, through the use of in vitro nuclear
transcription techniques with truncated templates. We have already
demonstrated that the 4S PAH-binding GNMT is a phosphorylated
protein with the probable sites of phosphorylation represented by
serine and/threonine. Upon definition of the specific amino acids,
site-specific mutagenesis of these amino acids will be accomplished
(by mutation to alanines). The hypothesis under test is that
phosphorylation of the 4S protein leads to enhanced function as a
PAH-binder, to increased translocation into the nucleus and to
increased transcriptional activation.
该实验室的总体目标是了解
多环芳烃(PAH) - 可诱导表达的表达
细胞色素P4501A1基因(CYP1A1)。 该法规似乎是
由与基因和反式作用相关的顺式元素介导
蛋白质。 诸如苯并(a)pyrene(b [a] p)之类的PAH可以与
高亲和力,以大鼠肝脏胞质4s的饱和方式饱和
以前已显示与甘氨酸鉴定的蛋白质
N-METHY1转移酶(GNMT)。 我们的初步结果表明
B [A] P可以诱导CYP1A1在AH受体中的表达
(ahr) - 无鼠标和该pah(以及其他几个)
诱导与已稳定转染的CHO细胞中的CYP1A1
GNMT基因(TCDD)在该系统中无效)。 父母
CHO细胞没有GNMT,AHR或ARNT表达
转染剂仅详细详细介绍GNMT。 以这些观察为基础
当前赠款的具体目的是确定:a)效果
CYP1A1和
根据其在AH受体肝脏中转录的速率
负小鼠和肝脏GNMT的水平,b)效果
将GNMT编码序列引入B [A] p-nonresponsive
通过测量稳态CYP1A1 mRNA水平和
它之前的转录速率和agter b [a] p处理以及
测量GNMT及其mRNA的稳定性,c)
GNMT的磷酸化,未磷酸化和
磷酸化形式在胞质和核之前/源前核[a] p之前,磷酸化形式,
磷酸化对GNMT功能的影响和
它的寡聚形式,d)GNMT的二聚体四聚体过渡
沉积分析和化学交联,E)的性质
磷酸化(和未磷酸化)4S GNMT的相互作用
使用CYP1A1的顺式元素,通过使用体外核
带有截短模板的转录技术。 我们已经
证明4S PAH结合GNMT是磷酸化的
蛋白质具有磷酸化的可能位点
丝氨酸和/苏氨酸。 根据特定氨基酸的定义
这些氨基酸的位点特异性诱变将得到完成
(通过突变到丙氨酸)。 正在测试的假设是
4S蛋白的磷酸化导致功能增强
pah-binder,增加易位到细胞核和到
增加转录激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD BRESNICK其他文献
EDWARD BRESNICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD BRESNICK', 18)}}的其他基金
GLYCINE N METHYL TRANSFERASE, A REGULATOR OF CYP1A1
甘氨酸 N 甲基转移酶,CYP1A1 的调节剂
- 批准号:
2377219 - 财政年份:1997
- 资助金额:
$ 25.35万 - 项目类别:
相似国自然基金
基于荧光共振能量转移及指示剂置换法策略纳米组装体比率荧光识别三磷酸腺苷
- 批准号:22361028
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
三磷酸腺苷驱动的高分子非平衡自组装体系及其可编程生物功能研究
- 批准号:22375074
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
去甲肾上腺素与三磷酸腺苷双位点荧光探针的构建及神经信号转导分子机制可视化解析
- 批准号:22307091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
三磷酸腺苷(ATP)诱导的短肽组装及物性研究
- 批准号:22202118
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
三磷酸腺苷(ATP)诱导的短肽组装及物性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating Parkin-mediated Neuronal Energy Maintenance in Methamphetamine Use Disorder
研究甲基苯丙胺使用障碍中 Parkin 介导的神经元能量维持
- 批准号:
10736697 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Deciphering a novel kinase function for adck2 in the heart
破译心脏中 adck2 的新激酶功能
- 批准号:
10664070 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Metabolic impact of Intralipid on synaptic function as a mechanism of resuscitation in local anesthetic systemic toxicity
脂肪乳对突触功能的代谢影响作为局麻药全身毒性复苏的机制
- 批准号:
10572885 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).
CNM-Au8 在肌萎缩侧索硬化症 (ALS) 中的中等规模扩展访问协议。
- 批准号:
10835565 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别:
Brain mitochondrial PET imaging and 31P-MR spectroscopy to dissect the role of mitochondrial dysfunction in bioenergetic dysregulation in Dementia with Lewy Bodies pathogenesis
脑线粒体 PET 成像和 31P-MR 光谱剖析线粒体功能障碍在路易体痴呆发病机制中生物能失调的作用
- 批准号:
10738869 - 财政年份:2023
- 资助金额:
$ 25.35万 - 项目类别: